Puma Biotechnology, Inc. (PBYI) Free Cash Flow
Puma Biotechnology, Inc. (PBYI) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$148.97M |
| 2017-12-31 | -$222.90M |
| 2018-12-31 | -$24.27M |
| 2019-12-31 | $22.38M |
| 2020-12-31 | -$9.27M |
| 2021-12-31 | $20.65M |
| 2022-12-31 | -$22.83M |
| 2023-12-31 | $14.37M |
| 2024-12-31 | $38.86M |
| 2025-12-31 | $41.73M |
How PBYI compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| AKBA | Akebia Therapeutics Inc. | $67.70M |
| AZTA | Azenta Inc. | $38.32M |
| NRC | National Research Corporation | $15.74M |
| ETON | Eton Pharmaceuticals Inc. | $10.19M |
| TXMD | TherapeuticsMD Inc. | $2.45M |
These are five companies in the same sector as PBYI with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Puma Biotechnology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("PBYI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PBYI | $9.60 | +0.84% | 0.33M |
| 3 | ||||
| 4 | ||||
| 5 |